Today: 7 February 2026
Subscribe

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

TSMC’s AI-Fueled Surge: Record Highs, Big Risks, and Bold Predictions (Oct 2025 Update)

TSMC’s AI-Fueled Surge: Record Highs, Big Risks, and Bold Predictions (Oct 2025 Update)

TSMC Stock Soars on AI Boom TSMC (Taiwan Semiconductor Manufacturing Co.) is riding a wave of investor enthusiasm as of October 2025. Its Taipei-listed shares hit record highs this month – reaching NT$1,370 on Oct 2 (about $43 USD per share) ts2.tech – and the U.S. ADR (NYSE: TSM) likewise surged to all-time highs, briefly trading above $300. In fact, TSMC’s U.S. stock spiked to an intraday $307 on Oct 7 amid frenzied buying ts2.tech. Even after a bit of profit-taking, TSMC hovers around the mid-$290s per share as of Oct 11, reflecting a dramatic upswing from roughly ~$200 at
11 October 2025
·····
Trump Media’s Wild Ride: DJT Stock Soars on Politics, Crypto & Controversy

Trump Media’s Wild Ride: DJT Stock Soars on Politics, Crypto & Controversy

Stock Price and Recent Performance As of mid-October 2025, DJT stock hovers around $15–$16, a far cry from its highs. It closed at $15.97 on October 10, 2025 investing.com investing.com, continuing a downward trend. The stock has lost roughly half its value in 2025 alone, and over the past year it’s down about 32% tickernerd.com. For context, DJT’s 52-week range spans from $15.42 up to $54.68 investing.com tickernerd.com – meaning it has collapsed about 70% from its peak. That peak came amid tremendous enthusiasm earlier in Trump’s presidential term, but momentum has since faded. Wild volatility is a hallmark of
11 October 2025
···
Robinhood’s Wild 2025 Ride: HOOD Stock Skyrockets 200%, Plunges 9% in a Day – What’s Next?

Robinhood’s Wild 2025 Ride: HOOD Stock Skyrockets 200%, Plunges 9% in a Day – What’s Next?

HOOD Stock Price and Recent Performance Robinhood’s stock has been on a rollercoaster in 2025. After starting the year at much lower levels, HOOD nearly tripled in value by early October. On October 6, shares hit a record intra-week high around $153. But by the week’s end, the stock pulled back sharply, closing at $138.96 on Oct 10 after an 8.9% single-day plunge ts2.tech. (The Oct 10 drop coincided with a broader market selloff sparked by renewed U.S.–China trade war fears, which particularly hit high-growth tech stocks ts2.tech.) Even after the pullback, Robinhood remains up over 200% year-to-date, vastly outperforming
11 October 2025
····
Quoin Pharma (QNRX) Stock Skyrockets 150% on Funding Deal – What’s Next?

Quoin Pharma (QNRX) Stock Skyrockets 150% on Funding Deal – What’s Next?

(Source: Nasdaq/GlobeNewswire, Reuters, TipRanks, Finviz, company filings.) Company Overview: Rare Disease Focus and Pipeline Progress Quoin Pharmaceuticals Ltd. is a clinical-stage biotech specializing in rare dermatological diseases. Headquartered in Ashburn, VA, Quoin’s mission is to deliver the first approved therapies for conditions that currently have none. “We remain fully focused on delivering the first approved therapy for Netherton Syndrome,” said CEO Dr. Michael Myers globenewswire.com. The company’s pipeline comprises three main product candidates targeting multiple orphan indications finviz.com: Until recently, Quoin had additional assets (QRX004 for epidermolysis bullosa, and QRX007 for Netherton) but shelved those programs in mid-2025 to concentrate
11 October 2025
····
Protagonist Therapeutics: Small Biotech Skyrockets on Buyout Buzz & Breakthrough Trials

Protagonist Therapeutics: Small Biotech Skyrockets on Buyout Buzz & Breakthrough Trials

Company Overview Protagonist Therapeutics is a clinical-stage biopharma company leveraging peptide technology to create new medicines for rare hematologic conditions and prevalent immunological diseasesprotagonist-inc.com. Founded in 2008, Protagonist has built its identity around engineered peptide drugs – a niche between small molecules and antibodies – to tackle challenging targets with oral or injectable therapies. The company’s mission centers on “developing groundbreaking new medicines to treat both rare and prevalent diseases” using its proprietary peptide platformprotagonist-inc.com. This focus has led to a pipeline addressing blood cancers/disorders and inflammatory bowel and skin diseases, where current treatments are inadequate. Leadership & Culture: President
11 October 2025
·······
Amazon Stock Today: AI Ambitions, $2.5B Twist, and $3 Trillion Dreams

Amazon Stock Today: AI Ambitions, $2.5B Twist, and $3 Trillion Dreams

Stock Price & Recent Performance Amazon’s stock has experienced back-and-forth swings in recent weeks. As of the market close on Oct. 10, 2025, AMZN stood at $216.37 per share stockanalysis.com. This price reflects a sudden drop at the end of the week – on Oct. 10 the stock plunged nearly 5% in a single day stockanalysis.com, part of a broader sell-off after U.S. President Trump threatened new 100% tariffs on Chinese imports and China tightened exports of rare earths (spooking tech investors) investopedia.com reuters.com. Prior to that downturn, Amazon had been gradually rebounding from a late-September dip: shares had bounced
11 October 2025
·····
Tesla Stock’s October Shock: Record Sales, New “Affordable” Models & Wall Street’s Verdict

Tesla Stock’s October Shock: Record Sales, New “Affordable” Models & Wall Street’s Verdict

Recent Stock Performance: From Rally to Pullback Tesla’s stock has seen dramatic swings in early October 2025. After trading in the low-$400s to start the month, TSLA spiked on October 6 ahead of a big product announcement, jumping ~5.4% in one session to close at $453.25 ts2.tech. That surge – adding over $70 billion in market cap – was fueled by optimism around record Q3 sales and a teased new model. It capped a strong short-term run: Tesla shares climbed roughly 7–8% over the first two weeks of October, outperforming the broader market (the S&P 500 rose more modestly) ts2.tech
11 October 2025
····
Rare Earth Goldmine? MP Materials Stock Skyrockets on Pentagon Deal & China Tensions

Rare Earth Goldmine? MP Materials Stock Skyrockets on Pentagon Deal & China Tensions

Spectacular Rally Fueled by Strategic Deals MP Materials’ stock performance in 2025 has been nothing short of remarkable. Shares have exploded higher on the back of transformative deals and the prospect of a secure American rare-earth supply chain. The stock is up nearly 4-fold this year, recently trading around $75–$80 per share ts2.tech. In late August, MP hit an all-time high near $82 before a brief pullback ts2.tech. Even after cooling slightly, shares remain ~350% above where they started the year. Elevated trading volume accompanied this rally (e.g. 13+ million shares on one day in late September, ~42% above average),
11 October 2025
····
Qualcomm (QCOM) Stock at a Crossroads: Will 5G & AI Ignite a 2025 Breakout or Stall Out?

Qualcomm (QCOM) Stock at a Crossroads: Will 5G & AI Ignite a 2025 Breakout or Stall Out?

Overview: Qualcomm’s Business & Core Technologies Qualcomm is an American multinational semiconductor company founded in 1985 and headquartered in San Diego, CA. It pioneered wireless communication technologies, notably the CDMA cellular standard in the 1990s, and today its inventions underlie many 3G/4G/5G standards en.wikipedia.org en.wikipedia.org. The company operates a fabless model (designing chips which are manufactured by partners like TSMC) and has two main segments: Qualcomm’s core technologies center on wireless connectivity (from 3G to 5G modems and now 6G research), mobile processing (high-performance, low-power chips with integrated CPU, GPU, AI engine, etc.), and an increasing focus on on-device AI.
11 October 2025
·····
Crypto Carnage: Tariff Bombshell Triggers $200B Crash as Ethereum Leads Liquidation Bloodbath

Crypto Carnage: Tariff Bombshell Triggers $200B Crash as Ethereum Leads Liquidation Bloodbath

Trade War Bombshell Sinks Crypto Markets The crypto market’s abrupt downturn in mid-October was triggered by a major geopolitical surprise. On October 10, President Trump revealed via social media that China had taken an “extremely hostile” stance on trade (limiting exports of critical rare-earth minerals) – and in response, he was preparing a “massive increase” in tariffs, including a 100% tariff on all Chinese imports effective Nov. 1 ts2.tech ts2.tech. This unexpected escalation of U.S.–China trade tensions hit markets like a shockwave. Almost immediately after Trump’s post, risk assets went into freefall. Bitcoin (which earlier that day hovered around $122K)
11 October 2025
·····
Tariff Trouble: 169‑Year‑Old Orvis Slashes Stores as It Returns to Its Outdoor Roots

Tariff Trouble: 169‑Year‑Old Orvis Slashes Stores as It Returns to Its Outdoor Roots

An Iconic Outfitter Scales Down Founded in 1856, Orvis is among America’s oldest outdoor retailers – a name synonymous with fly fishing rods, tackle, and rustic New England sporting tradition. Over nearly 170 years, the family-run company grew from a small Vermont tackle shop into a national premium brand with dozens of stores selling not just fishing gear and hunting shotguns, but apparel, home furnishings, dog beds, luggage, and more. By the mid-2010s, Orvis operated around 80 stores and had a thriving catalog business mailing out millions of catalogs annually. But in recent years, the retailer’s footprint and focus have
11 October 2025
·
1 … 142 143 144 145 146 … 233

Stock Market Today

SGX share price dips at week’s end after record profit; what investors watch next

SGX share price dips at week’s end after record profit; what investors watch next

7 February 2026
Singapore Exchange shares closed 0.4% lower at S$17.57 on Friday, despite reporting record half-year results and a higher dividend earlier in the week. Broker targets diverged after the update, with Maybank and DBS raising targets while Citi stayed bearish. Investors are watching for signs of momentum from derivatives and equity-market reforms as the next session opens Monday.
South32 share price drops 4% in ASX rout — what investors watch before results

South32 share price drops 4% in ASX rout — what investors watch before results

7 February 2026
South32 shares fell 4.1% to A$4.41 Friday as Australian miners dropped in the worst ASX session since April 2025. The S&P/ASX 200 lost 2%, erasing almost A$70 billion in value. South32’s half-year results and interim dividend decision are set for Feb. 12. Markets reopen Monday with investors watching for further volatility.
Go toTop